The Incidence of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer

被引：0
|
作者：
Kenmotsu, Hirotsugu [1 ]
Naito, Tateaki [1 ]
Ono, Akira [1 ]
Nakamura, Yukiko [1 ]
Tsuya, Asuka [1 ]
Kaira, Kyoichi [1 ]
Murakami, Haruyasu [1 ]
Takahashi, Toshiaki [1 ]
Endo, Masahiro [2 ]
Yamamoto, Nobuyuki [1 ]
机构：
[1] Shizuoka Canc Ctr Hosp, Dept Thorac Oncol, Shizuoka, Japan
[2] Shizuoka Canc Ctr Hosp, Dept Diagnost Radiol, Shizuoka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S414 / S415
页数：2
相关论文
共 50 条
  • [1] The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kimura, Madoka
    Ono, Akira
    Shukuya, Takehito
    Nakamura, Yukiko
    Tsuya, Asuka
    Kaira, Kyoichi
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) : 1242 - 1246
  • [2] The Risk Of Chemotherapy-Related Exacerbation Of Interstitial Lung Disease With Lung Cancer
    Kenmotsu, H.
    Naito, T.
    Akamatsu, H.
    Ono, A.
    Shukuya, T.
    Nakamura, Y.
    Tsuya, A.
    Kaira, K.
    Murakami, H.
    Takahashi, T.
    Endo, M.
    Yamamoto, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [3] Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease
    Akaike, Kimitaka
    Saruwatari, Koichi
    Oda, Seitaro
    Hamada, Shohei
    Tomita, Yusuke
    Saeki, Sho
    Ichiyasu, Hidenori
    Fujii, Kazuhiko
    Shiraishi, Shinya
    Sakagami, Takuro
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
    Sekine, Akimasa
    Matama, Goushi
    Hagiwara, Eri
    Tabata, Erina
    Ikeda, Satoshi
    Oda, Tsuneyuki
    Okuda, Ryo
    Kitamura, Hideya
    Baba, Tomohisa
    Satoh, Hiroaki
    Misumi, Toshihiro
    Komatsu, Shigeru
    Iwasawa, Tae
    Ogura, Takashi
    THORACIC CANCER, 2022, 13 (17) : 2443 - 2449
  • [5] Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer
    Ozawa, Yuichi
    Akahori, Daisuke
    Koda, Keigo
    Abe, Takefumi
    Hasegawa, Hirotsugu
    Matsui, Takashi
    Tanahashi, Masayuki
    Niwa, Hiroshi
    Yamada, Kazunari
    Yokomura, Koshi
    Suda, Takafumi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (05) : 1031 - 1038
  • [6] Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer
    Yuichi Ozawa
    Daisuke Akahori
    Keigo Koda
    Takefumi Abe
    Hirotsugu Hasegawa
    Takashi Matsui
    Masayuki Tanahashi
    Hiroshi Niwa
    Kazunari Yamada
    Koshi Yokomura
    Takafumi Suda
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1031 - 1038
  • [7] The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer
    Masuda, Takeshi
    Hirano, Chihiro
    Horimasu, Yasushi
    Nakashima, Taku
    Miyamoto, Shintarou
    Iwamoto, Hiroshi
    Ohshimo, Shinichiro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 131 - 139
  • [8] The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer
    Takeshi Masuda
    Chihiro Hirano
    Yasushi Horimasu
    Taku Nakashima
    Shintarou Miyamoto
    Hiroshi Iwamoto
    Shinichiro Ohshimo
    Kazunori Fujitaka
    Hironobu Hamada
    Noboru Hattori
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 131 - 139
  • [9] Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer
    Hamada, Shohei
    Ichiyasu, Hidenori
    Ikeda, Tokunori
    Inaba, Megumi
    Kashiwabara, Kosuke
    Sadamatsu, Tomoki
    Sato, Nahoko
    Akaike, Kimitaka
    Okabayashi, Hiroko
    Saruwatari, Koichi
    Tomita, Yusuke
    Saeki, Sho
    Hirata, Naomi
    Yoshinaga, Takeshi
    Fujii, Kazuhiko
    BMC PULMONARY MEDICINE, 2019, 19 (1)
  • [10] Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer
    Shohei Hamada
    Hidenori Ichiyasu
    Tokunori Ikeda
    Megumi Inaba
    Kosuke Kashiwabara
    Tomoki Sadamatsu
    Nahoko Sato
    Kimitaka Akaike
    Hiroko Okabayashi
    Koichi Saruwatari
    Yusuke Tomita
    Sho Saeki
    Naomi Hirata
    Takeshi Yoshinaga
    Kazuhiko Fujii
    BMC Pulmonary Medicine, 19
12345